Clal Insurance’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.6M | Buy |
3,913,014
+570,000
| +17% | +$9.12M | 0.62% | 44 |
|
|
2025
Q1 | $65M | Sell |
3,343,014
-153,095
| -4% | -$2.97M | 0.67% | 38 |
|
|
2024
Q4 | $77M | Sell |
3,496,109
-469,838
| -12% | -$10.4M | 0.69% | 33 |
|
|
2024
Q3 | $66.8M | Sell |
3,965,947
-3,688,828
| -48% | -$62.1M | 0.59% | 42 |
|
|
2024
Q2 | $91.5M | Buy |
7,654,775
+1,582,663
| +26% | +$18.9M | 0.96% | 29 |
|
|
2024
Q1 | $63M | Sell |
6,072,112
-1,014,046
| -14% | -$10.5M | 0.71% | 38 |
|
|
2023
Q4 | $56.4M | Buy |
7,086,158
+514,858
| +8% | +$4.1M | 0.74% | 35 |
|
|
2023
Q3 | $45.3M | Buy |
+6,571,300
| New | +$45.3M | 0.63% | 39 |
|